Követés
FRANCESCO MAURA
FRANCESCO MAURA
E-mail megerősítve itt: med.miami.edu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal
TJ Mitchell, S Turajlic, A Rowan, D Nicol, JHR Farmery, T O’Brien, ...
Cell 173 (3), 611-623. e17, 2018
4612018
The mutational landscape of normal human endometrial epithelium
L Moore, D Leongamornlert, THH Coorens, MA Sanders, P Ellis, ...
Nature 580 (7805), 640-646, 2020
3812020
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
B Rodriguez-Martin, EG Alvarez, A Baez-Ortega, J Zamora, F Supek, ...
Nature genetics 52 (3), 306-319, 2020
3092020
Genomic landscape and chronological reconstruction of driver events in multiple myeloma
F Maura, N Bolli, N Angelopoulos, KJ Dawson, D Leongamornlert, ...
Nature communications 10 (1), 3835, 2019
2392019
Genomic patterns of progression in smoldering multiple myeloma
N Bolli, F Maura, S Minvielle, D Gloznik, R Szalat, A Fullam, ...
Nature communications 9 (1), 3363, 2018
1852018
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
N Bolli, G Biancon, M Moarii, S Gimondi, Y Li, C de Philippis, F Maura, ...
Leukemia 32 (12), 2604-2616, 2018
1822018
A practical guide for mutational signature analysis in hematological malignancies
F Maura, A Degasperi, F Nadeu, D Leongamornlert, H Davies, L Moore, ...
Nature communications 10 (1), 2969, 2019
1612019
Timing the initiation of multiple myeloma
EH Rustad, V Yellapantula, D Leongamornlert, N Bolli, G Ledergor, ...
Nature communications 11 (1), 1917, 2020
1302020
Autoimmune cytopenias in chronic lymphocytic leukemia
C Visco, W Barcellini, F Maura, A Neri, A Cortelezzi, F Rodeghiero
American journal of hematology 89 (11), 1055-1062, 2014
1292014
Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines
F Maura, M Petljak, M Lionetti, I Cifola, W Liang, E Pinatel, LB Alexandrov, ...
Leukemia 32 (4), 1043-1047, 2018
962018
Revealing the impact of structural variants in multiple myeloma
EH Rustad, VD Yellapantula, D Glodzik, KH Maclachlan, B Diamond, ...
Blood cancer discovery 1 (3), 258-273, 2020
892020
Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: a comparison of cellular, cytogenetic, molecular, and clinical features
F Morabito, L Mosca, G Cutrona, L Agnelli, G Tuana, M Ferracin, B Zagatti, ...
Clinical cancer research 19 (21), 5890-5900, 2013
862013
COVID-19 infections and clinical outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
M Hultcrantz, J Richter, CA Rosenbaum, D Patel, EL Smith, N Korde, ...
Blood cancer discovery 1 (3), 234-243, 2020
802020
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
B Oben, G Froyen, KH Maclachlan, D Leongamornlert, F Abascal, ...
Nature communications 12 (1), 1861, 2021
742021
The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma
EM Boyle, S Deshpande, R Tytarenko, C Ashby, Y Wang, MA Bauer, ...
Nature communications 12 (1), 293, 2021
722021
High‐throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications
M Lionetti, S Fabris, G Cutrona, L Agnelli, C Ciardullo, S Matis, G Ciceri, ...
British journal of haematology 165 (5), 629-639, 2014
662014
Safety and effectiveness of weekly carfilzomib, lenalidomide, dexamethasone, and daratumumab combination therapy for patients with newly diagnosed multiple myeloma: the …
O Landgren, M Hultcrantz, B Diamond, AM Lesokhin, S Mailankody, ...
JAMA oncology 7 (6), 862-868, 2021
652021
Detection of early seeding of Richter transformation in chronic lymphocytic leukemia
F Nadeu, R Royo, R Massoni-Badosa, H Playa-Albinyana, B Garcia-Torre, ...
Nature medicine 28 (8), 1662-1671, 2022
632022
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
G Collord, P Tarpey, N Kurbatova, I Martincorena, S Moran, M Castro, ...
Scientific reports 8 (1), 13537, 2018
562018
Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: a single-arm, single-centre, phase 2 trial
B Diamond, N Korde, AM Lesokhin, EL Smith, U Shah, S Mailankody, ...
The Lancet Haematology 8 (6), e422-e432, 2021
542021
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20